Insider Trading & Ownership of ROBERT NELSEN

Location: Chicago, IL
Summary: The estimated net worth of ROBERT NELSEN is at least $341M dollars as of 05 Aug 2025. ROBERT NELSEN is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $178M. ROBERT NELSEN is the Director, 10%+ Owner of Lyell Immunopharma, Inc. and owns shares of Lyell Immunopharma, Inc. (LYEL) stock worth about $83M. ROBERT NELSEN is the Director, 10%+ Owner of Prime Medicine, Inc. and owns shares of Prime Medicine, Inc. (PRME) stock worth about $73.9M. ROBERT NELSEN is the Director of Vir Biotechnology, Inc. and owns shares of Vir Biotechnology, Inc. (VIR) stock worth about $5.87M.
Signature: /s/ Ryan Brown, attorney-in-fact
All Insider Reports: All Insider Reports

Notify me when ROBERT NELSEN files a new Insider Trading report.

Ownership of ROBERT NELSEN

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
DNLI	Denali Therapeutics Inc.	Director	$178M			02 Jun 2021
LYEL	Lyell Immunopharma, Inc.	Director, 10%+ Owner	$83M			14 Jun 2024
PRME	Prime Medicine, Inc.	Director, 10%+ Owner	$73.9M	+$10M	+15.6%	01 Aug 2025
VIR	Vir Biotechnology, Inc.	Director	$5.87M			30 May 2024
SANA	Sana Biotechnology, Inc.	Director, 10%+ Owner				05 Jun 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.